Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQXT.L Regulatory News (QXT)

  • There is currently no data for QXT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity and Director/PDMR Shareholding

27 Oct 2017 17:15

RNS Number : 8910U
Quixant PLC
27 October 2017
 

Quixant plc

("Quixant" or the "Company")

 

Issue of Equity and Director/PDMR Shareholding

 

Quixant (AIM: QXT), a leading provider of specialised computing platforms for gaming and slot machine applications and accessories, today announces that it has applied to the London Stock Exchange for 105,000 ordinary shares of £0.001 pence each in the Company ("Ordinary Shares") to be admitted to trading on AIM ("Admission"). The new Ordinary Shares are being issued subsequent to exercises of options over Ordinary Shares ("Options") by certain Directors', persons discharging managerial responsibilities ("PDMR's") and employees of the Company.

 

On 27 October 2017, Cresten Preddy, Finance Director of the Company, exercised Options on 10,000 Ordinary Shares. On Admission Cresten Preddy will hold 40,000 Ordinary Shares, representing approximately 0.06% of the Company's issued share capital.

 

Furthermore, on 27 October 2017 the following PDMR's of the Company exercised Options and subsequently sold Ordinary Shares (in certain cases) as follows:

 

PDMR

Role

Options exercised

Ordinary Shares subsequently sold

John Malin

Sales Director, Quixant UK Ltd

5,000

5,000

Sandra Lowman

Operations Director, Quixant UK Ltd

33,000

-

Amit Sharma

Vice President Sales & General Manager, Quixant USA Inc

18,000

18,000

 

Total Voting Rights

It is expected that Admission will become effective and trading will commence in the new Ordinary Shares at 8.00 a.m. on 2 November 2017. On Admission the Company's issued share capital will comprise 66,034,982 Ordinary Shares. The Company holds no Ordinary Shares in treasury. Accordingly, the figure of 66,034,982 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

For further information please contact:

 

Quixant plc

Tel: +44 (0)1223 892 696

Jon Jayal, Chief Operating Officer

Nominated Adviser and Broker:

Tel: +44 (0)20 7220 0500

finnCap

Matt Goode / Grant Bergman (Corporate Finance)

Simon Johnson / Alice Lane (Corporate Broking)

Financial PR:

Alma PR

Tel: +44 (0)20 8004 4217

John Coles

Hilary Buchanan

Susie Hudson

 

 

About Quixant

Quixant, founded in 2005, designs and manufactures highly optimised computing solutions and monitors principally for the global gaming industry. The Company is headquartered in Cambridge in the UK where the global sales function is based. North America sales and sales support is run from their subsidiary in Las Vegas. Quixant has its own manufacturing and engineering operation based in Taiwan and software engineering and customer support team based in Italy. All the specialised products software and manufacturing are produced in-house and Quixant owns all its own IP much of which is copyright protected.

 

In November 2015 Quixant acquired Densitron Technologies plc. Densitron has a strong heritage in the sale of electronic display solutions to global industrial markets. Through Densitron's experienced sales team, Quixant has a robust platform to build its business into wider industrial markets.

 

In-depth information on the Company's products, markets, activities and history can be found on the corporate website at www.quixant.com.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

- Cresten Preddy - Finance Director

- John Malin - Sales Director, Quixant UK Ltd

- Sandra Lowman - Operations Director, Quixant UK Ltd

- Amit Sharma - Vice President Sales & General Manager, Quixant USA Inc

2.

Reason for the notification

a)

Position/status:

PDMR's

b)

Initial notification/Amendment:

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Quixant plc

 

b)

LEI:

2138003VERWSQP561X71

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

 

Identification code:

Ordinary Shares of £0.001

 

 

GB00B99PCP71

 

b)

Nature of the transaction:

Exercise of Options over Ordinary Shares

c)

Price(s) and volume(s):

- Cresten Preddy

Price(s)

Volume(s)

49 pence

10,000

 

- John Malin

Price(s)

Volume(s)

49 pence

5,000

 

- Sandra Lowman

Price(s)

Volume(s)

49 pence

33,000

 

- Amit Sharma

Price(s)

Volume(s)

49 pence

18,000

d)

Aggregated information:

· Aggregated volume:

· Price:

See 4(c) above

e)

Date of the transaction:

27 October 2017

 

f)

Place of the transaction:

London Stock Exchange, AIM Market (XLON)

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

- John Malin - Sales Director, Quixant UK Ltd

- Amit Sharma - Vice President Sales & General Manager, Quixant USA Inc

2.

Reason for the notification

a)

Position/status:

PDMR's

b)

Initial notification/Amendment:

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Quixant plc

 

b)

LEI:

2138003VERWSQP561X71

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

 

Identification code:

Ordinary Shares of £0.001

 

 

GB00B99PCP71

 

b)

Nature of the transaction:

Sale of Ordinary Shares

c)

Price(s) and volume(s):

- John Malin

Price(s)

Volume(s)

£4.458254 pence

5,000

 

- Amit Sharma

Price(s)

Volume(s)

£4.458254 pence

18,000

d)

Aggregated information:

· Aggregated volume:

· Price:

See 4(c) above

e)

Date of the transaction:

27 October 2017

 

f)

Place of the transaction:

London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEMMMZGVNGGNZM
Date   Source Headline
10th Dec 20209:00 amRNSPrice Monitoring Extension
10th Dec 20207:00 amRNSTrading Update
17th Nov 20205:52 pmRNSHolding(s) in Company
27th Oct 20207:00 amRNSExercise of Options
14th Oct 20206:15 pmRNSHolding(s) in Company
13th Oct 20207:00 amRNSDirector Shareholding
12th Oct 20203:17 pmRNSGrant of Options
7th Oct 20205:26 pmRNSHolding(s) in Company
30th Sep 20207:00 amRNSInterim Results
19th Aug 20207:00 amRNSAppointment of Interim CFO
10th Aug 20207:00 amRNSChanges to the Board of Directors
23rd Jul 20204:45 pmRNSHolding(s) in Company
23rd Jul 20204:05 pmRNSHolding(s) in Company
22nd Jul 20207:00 amRNSTrading Update and Notice of Results
3rd Jul 20205:57 pmRNSHolding(s) in Company
3rd Jul 20205:57 pmRNSHolding(s) in Company
19th May 20204:21 pmRNSResult of AGM
19th May 20207:00 amRNSTrading Update
6th May 20204:41 pmRNSSecond Price Monitoring Extn
6th May 20204:35 pmRNSPrice Monitoring Extension
29th Apr 20204:42 pmRNSSecond Price Monitoring Extn
29th Apr 20204:36 pmRNSPrice Monitoring Extension
28th Apr 20207:00 amRNSDirector/PDMR Shareholding
27th Apr 20207:00 amRNSDesignate Director Shareholding
23rd Apr 20207:00 amRNSAppointment of Non-Executive Director
6th Apr 20207:00 amRNSAudited Final Results
3rd Apr 202012:23 pmRNSHolding(s) in Company
31st Mar 20207:00 amRNS2019 Trading and COVID-19 update
27th Mar 20203:08 pmRNSTiming of Results
26th Mar 20204:50 pmRNSBoard Change
19th Mar 202012:50 pmRNSHolding(s) in Company
18th Mar 20207:00 amRNSNotice of Results Update
12th Feb 20205:44 pmRNSHolding(s) in Company
29th Jan 20207:00 amRNSTrading Update and Notice of Results
20th Dec 20195:50 pmRNSHolding(s) in Company
24th Oct 20194:13 pmRNSDirector/PDMR Shareholding
22nd Oct 20193:05 pmRNSHolding(s) in Company
22nd Oct 20193:05 pmRNSHolding(s) in Company
14th Oct 20194:10 pmRNSDirector/PDMR Shareholding
7th Oct 20195:14 pmRNSDirector/PDMR Transfer Shareholding
27th Sep 20193:41 pmRNSHolding(s) in Company
23rd Sep 20193:09 pmRNSDirector/PDMR Shareholding
19th Sep 20194:13 pmRNSDirector/PDMR Shareholding
18th Sep 20194:54 pmRNSDirector/PDMR Shareholding
17th Sep 20199:05 amRNSSecond Price Monitoring Extn
17th Sep 20199:00 amRNSPrice Monitoring Extension
17th Sep 20197:00 amRNSInterim Results
23rd Jul 20197:00 amRNSTrading Update and Notice of Results
22nd Jul 201911:54 amRNSExercise of Options
4th Jul 20197:00 amRNSCompany Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.